149 related articles for article (PubMed ID: 18417901)
1. Sarcomatoid squamous cell carcinoma of uterine cervix: pathology, imaging, and treatment.
Kumar M; Bahl A; Sharma DN; Agarwal S; Halanaik D; Kumar R; Rath GK
J Cancer Res Ther; 2008; 4(1):39-41. PubMed ID: 18417901
[TBL] [Abstract][Full Text] [Related]
2. Sarcomatoid squamous cell carcinoma of the uterine cervix: case report.
Rodrigues L; Santana I; Cunha T; Félix A; Freire J; Cabral I
Eur J Gynaecol Oncol; 2000; 21(3):287-9. PubMed ID: 10949396
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
[TBL] [Abstract][Full Text] [Related]
4. Sarcomatoid squamous cell carcinoma of the uterine cervix with osteoclast-like giant cells: report of two cases.
Pang LC
Int J Gynecol Pathol; 1998 Apr; 17(2):174-7. PubMed ID: 9553816
[TBL] [Abstract][Full Text] [Related]
5. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.
Lorvidhaya V; Chitapanarux I; Sangruchi S; Lertsanguansinchai P; Kongthanarat Y; Tangkaratt S; Visetsiri E
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1226-32. PubMed ID: 12654431
[TBL] [Abstract][Full Text] [Related]
6. Splenic metastases from cervical carcinoma: a case report.
Gupta T; Nair N; Fuke P; Bedre G; Basu S; Shrivastava SK
Int J Gynecol Cancer; 2006; 16(2):911-4. PubMed ID: 16681784
[TBL] [Abstract][Full Text] [Related]
7. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix.
Lee MY; Wu HG; Kim K; Ha SW; Kim JS; Kim IA; Lee HP
Gynecol Oncol; 2007 Jan; 104(1):95-9. PubMed ID: 16996117
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of pretreatment and after treatment 18F-FDG PET/CT metabolic parameters in patients with locally advanced squamous cell cervical cancer.
Yilmaz B; Dağ S; Ergul N; Çermik TF
Nucl Med Commun; 2019 Mar; 40(3):219-227. PubMed ID: 30585896
[TBL] [Abstract][Full Text] [Related]
9. Roles of posttherapy
Liu FY; Su TP; Wang CC; Chao A; Chou HH; Chang YC; Yen TC; Lai CH
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1197-1204. PubMed ID: 29470614
[TBL] [Abstract][Full Text] [Related]
10. [Glassy cell carcinoma of the cervix].
Dieterle S; Mesrogli M; Günter HH; Kühnle H
Geburtshilfe Frauenheilkd; 1991 Jun; 51(6):484-5. PubMed ID: 1909675
[TBL] [Abstract][Full Text] [Related]
11. Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET.
Olsen JR; Dehdashti F; Siegel BA; Zighelboim I; Grigsby PW; Schwarz JK
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):772-7. PubMed ID: 20888130
[TBL] [Abstract][Full Text] [Related]
12. Rapid developing basaloid squamous cell carcinoma of the uterine cervix in a young adult Taiwanese.
Tsai HJ; Liou B; Li MC
Malays J Pathol; 2013 Dec; 35(2):177-80. PubMed ID: 24362481
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy in squamous cell carcinoma of the cervix uteri: present role and perspectives.
Pignata S; De Vivo R; Ricchi P; Perrone F; Botti G; Monfardini S
Cancer Treat Rev; 1998 Feb; 24(1):27-34. PubMed ID: 9606366
[No Abstract] [Full Text] [Related]
14. The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
Li X; Wei LC; Zhang Y; Zhao LN; Li WW; Ping LJ; Dang YZ; Hu J; Shi M
Int J Gynecol Cancer; 2016 Oct; 26(8):1472-9. PubMed ID: 27400321
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer.
Oh D; Lee JE; Huh SJ; Park W; Nam H; Choi JY; Kim BT
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):549-54. PubMed ID: 24074928
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of 2-deoxy-2-[18F]fluoro-D-glucose (FDG)-positron emission tomography (PET) on treatment choice in recurrent cancer of the cervix uteri.
Bjurberg M; Brun E
Int J Gynecol Cancer; 2013 Nov; 23(9):1642-6. PubMed ID: 24177254
[TBL] [Abstract][Full Text] [Related]
17. Multidisciplinary approach in the pelvic relapse of a previously irradiated cervical tumor.
Vázquez-Vicente D; Castellanos T; Cabello A; Chacon E; Minguez JA; Chiva L
Int J Gynecol Cancer; 2020 May; 30(5):714. PubMed ID: 32122948
[No Abstract] [Full Text] [Related]
18. Concurrent Cisplatin-Based Chemoradiation in Squamous Cell Carcinoma of Cervix.
Hashmi H; Maqbool A; Ahmed S; Ahmed A; Sheikh K; Ahmed A
J Coll Physicians Surg Pak; 2016 Apr; 26(4):302-5. PubMed ID: 27097702
[TBL] [Abstract][Full Text] [Related]
19. Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by positron emission tomography and treated with curative intent.
Narayan K; Fisher RJ; Bernshaw D; Shakher R; Hicks RJ
Int J Gynecol Cancer; 2009 Jul; 19(5):912-8. PubMed ID: 19574784
[TBL] [Abstract][Full Text] [Related]
20. Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.
Hirakawa M; Nagai Y; Inamine M; Kamiyama K; Ogawa K; Toita T; Murayama S; Aoki Y
Gynecol Oncol; 2008 Jan; 108(1):126-9. PubMed ID: 17936344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
